Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels.

The genetic determinants of variation in iron status are actively sought, but remain incompletely understood. Meta-analysis of two genome-wide association (GWA) studies and replication in three independent cohorts was performed to identify genetic loci associated in the general population with serum levels of iron and markers of iron status, including transferrin, ferritin, soluble transferrin receptor (sTfR) and sTfR-ferritin index. We identified and replicated a novel association of a common variant in the type-2 transferrin receptor (TFR2) gene with iron levels, with effect sizes highly consistent across samples. In addition, we identified and replicated an association between the HFE locus and ferritin and confirmed previously reported associations with the TF, TMPRSS6 and HFE genes. The five replicated variants were tested for association with expression levels of the corresponding genes in a publicly available data set of human liver samples, and nominally statistically significant expression differences by genotype were observed for all genes, although only rs3811647 in the TF gene survived the Bonferroni correction for multiple testing. In addition, we measured for the first time the effects of the common variant in TMPRSS6, rs4820268, on hepcidin mRNA in peripheral blood (n = 83 individuals) and on hepcidin levels in urine (n = 529) and observed an association in the same direction, though only borderline significant. These functional findings require confirmation in further studies with larger sample sizes, but they suggest that common variants in TMPRSS6 could modify the hepcidin-iron feedback loop in clinically unaffected individuals, thus making them more susceptible to imbalances of iron homeostasis.

[1]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[2]  S. Bandinelli,et al.  Proinflammatory state, hepcidin, and anemia in older persons. , 2010, Blood.

[3]  Xia Yang,et al.  Liver and Adipose Expression Associated SNPs Are Enriched for Association to Type 2 Diabetes , 2010, PLoS genetics.

[4]  A. Ikai,et al.  Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy. , 2010, Journal of molecular biology.

[5]  Toshiko Tanaka,et al.  A genome-wide association analysis of serum iron concentrations. , 2010, Blood.

[6]  G. Weiss Genetic mechanisms and modifying factors in hereditary hemochromatosis , 2010, Nature Reviews Gastroenterology &Hepatology.

[7]  Christian Gieger,et al.  A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium , 2009, Nature Genetics.

[8]  Gonçalo Abecasis,et al.  Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels , 2009, Nature Genetics.

[9]  Ian H. Frazer,et al.  Common variants in TMPRSS6 are associated with iron status and erythrocyte volume , 2009, Nature Genetics.

[10]  Christian Gieger,et al.  Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.

[11]  Gloria Velasco,et al.  Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis , 2009, Haematologica.

[12]  C. Datz,et al.  Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. , 2009, Blood.

[13]  Leena Peltonen,et al.  Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. , 2009, American journal of human genetics.

[14]  M. Muckenthaler,et al.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. , 2009, Journal of Alzheimer's disease : JAD.

[15]  G. Abecasis,et al.  Genotype imputation. , 2009, Annual review of genomics and human genetics.

[16]  Jerry Kaplan,et al.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.

[17]  D. Girelli,et al.  Immunoassay for human serum hepcidin. , 2008, Blood.

[18]  M. Cazzola,et al.  A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron , 2008, Haematologica.

[19]  C. López-Otín,et al.  Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. , 2008, Blood.

[20]  D. Schwartz,et al.  The role of correction of anaemia in patients with congestive heart failure: A short review , 2008, European journal of heart failure.

[21]  D. Girelli,et al.  Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry , 2008, PloS one.

[22]  M. Muckenthaler Fine tuning of hepcidin expression by positive and negative regulators. , 2008, Cell metabolism.

[23]  Ramaiah Nagaraja,et al.  Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. , 2008, American journal of human genetics.

[24]  B. Beutler,et al.  The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency , 2008, Science.

[25]  N. Andrews,et al.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.

[26]  Thomas J. Hudson,et al.  Differential Allelic Expression in the Human Genome: A Robust Approach To Identify Genetic and Epigenetic Cis-Acting Mechanisms Regulating Gene Expression , 2008, PLoS genetics.

[27]  V. Felitti,et al.  Screening for hemochromatosis by measuring ferritin levels: a more effective approach. , 2007, Blood.

[28]  Jerry Kaplan,et al.  Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.

[29]  M. Devoto,et al.  Estimates of Genetic and Environmental Contribution to 43 Quantitative Traits Support Sharing of a Homogeneous Environment in an Isolated Population from South Tyrol, Italy , 2007, Human Heredity.

[30]  W. Fawzi,et al.  Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression. , 2007, The Journal of nutrition.

[31]  N. Andrews,et al.  Iron homeostasis. , 2007, Annual review of physiology.

[32]  Thomas Meitinger,et al.  The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives , 2007, BMC Medical Genetics.

[33]  C. V. van Duijn,et al.  Heritability of Serum Iron, Ferritin and Transferrin Saturation in a Genetically Isolated Population, the Erasmus Rucphen Family (ERF) Study , 2006, Human Heredity.

[34]  G. Abecasis,et al.  Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians , 2006, PLoS genetics.

[35]  V. Subramaniam,et al.  First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin , 2005, Gut.

[36]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[37]  Paige S. Davies,et al.  Expression of the Hereditary Hemochromatosis Protein HFE Increases Ferritin Levels by Inhibiting Iron Export in HT29 Cells* , 2004, Journal of Biological Chemistry.

[38]  M. Hentze,et al.  Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.

[39]  J. Manson,et al.  Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. , 2004, JAMA.

[40]  G. Novelli,et al.  Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy , 2004, BMC Medical Genetics.

[41]  M. Cazzola,et al.  Differential HFE allele expression in hemochromatosis heterozygotes. , 2001, Gastroenterology.

[42]  Luigi Ferrucci,et al.  Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI Study , 2000, Journal of the American Geriatrics Society.

[43]  G. Béréziat,et al.  Differential HFE allele expression in hemochromatosis heterozygotes. , 2000, Gastroenterology.

[44]  Paolo Gasparini,et al.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.

[45]  D. Duffy,et al.  Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. , 2000, American journal of human genetics.

[46]  W. Sly,et al.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Koeffler,et al.  Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.

[48]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[49]  I. Rossman,et al.  Normal Human Aging: The Baltimore Longitudinal Study of Aging , 1986 .

[50]  David Arenberg,et al.  Normal Human Aging: The Baltimore Longitudinal Study on Aging , 1984 .